Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COA6 antisense RNA 1 (COA6-AS1) is a long non-coding RNA gene found in humans, transcribed as an antisense RNA overlapping the COA6 locus. As an lncRNA, COA6-AS1 may potentially regulate the expression of the COA6 gene through antisense interaction but its direct biological functions, relevance as a therapeutic target, disease associations, or biomarker status are presently not characterized or substantiated in the literature[5][6]. COA6-AS1 is categorized under long non-coding RNAs, listed with alternate identifiers including HGNC:40825, NCBI Gene:101927765, and Ensembl:ENSG00000231663[5]. For further structured annotation, it is important to note that while antisense lncRNAs (as a class) can regulate gene expression and show relevance in cancer and inflammatory diseases[6][1], specific data for COA6-AS1's function, disease involvement, or targeting are unavailable, and no therapies or drugs are known to interact with this RNA molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COA6 antisense RNA 1 (COA6-AS1).